Sonnet Biotherapeutics Holdings Inc expected to post earnings of 14 cents a share - Earnings Preview

Sonnet Biotherapeutics Holdings

06/05/2024 18:35

* Sonnet Biotherapeutics Holdings Inc  SONN.OQ   SONN.O  is
expected to show a fall in quarterly revenue when it reports 
results on May 8 (estimated) for the period ending March 31 2024
    * The Princeton New Jersey-based  company is expected to
report a
66.2% decrease in revenue to $12.33 thousand from $36.45
thousand a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Sonnet Biotherapeutics
Holdings Inc is for earnings of 14 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sonnet
Biotherapeutics Holdings Inc is $20.50​, above​ its last closing
price of $1.86. ​​​

This summary was machine generated May 6 at 17:35 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)